Innovation1 Biotech Inc. (IVBT)
OTCMKTS
· Delayed Price · Currency is USD
0.0050
0.00 (0.00%)
May 9, 2025, 4:00 PM EDT
Innovation1 Biotech Statistics
Total Valuation
IVBT has a market cap or net worth of 112,351. The enterprise value is 617,971.
Market Cap | 112,351 |
Enterprise Value | 617,971 |
Important Dates
The next estimated earnings date is Friday, July 11, 2025.
Earnings Date | Jul 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
IVBT has 22.47 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 22.47M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +6.38% |
Owned by Insiders (%) | 61.86% |
Owned by Institutions (%) | n/a |
Float | 8.57M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -0.03 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.10 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
Current Ratio | 0.04 |
Quick Ratio | 0.04 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1.51 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -21.74% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 24.74% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +525.00% in the last 52 weeks. The beta is 5.83, so IVBT's price volatility has been higher than the market average.
Beta (5Y) | 5.83 |
52-Week Price Change | +525.00% |
50-Day Moving Average | 0.00 |
200-Day Moving Average | 0.00 |
Relative Strength Index (RSI) | 94.94 |
Average Volume (20 Days) | 126 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -688,401 |
Pretax Income | -5.30M |
Net Income | -6.21M |
EBITDA | -687,354 |
EBIT | -688,401 |
Earnings Per Share (EPS) | -0.30 |
Balance Sheet
The company has 107,527 in cash and 605,062 in debt, giving a net cash position of -497,535 or -0.02 per share.
Cash & Cash Equivalents | 107,527 |
Total Debt | 605,062 |
Net Cash | -497,535 |
Net Cash Per Share | -0.02 |
Equity (Book Value) | -3.34M |
Book Value Per Share | -0.15 |
Working Capital | -2.79M |
Cash Flow
Operating Cash Flow | -515,397 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
IVBT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -11.48% |
Shareholder Yield | -11.48% |
Earnings Yield | -5,529.07% |
FCF Yield | n/a |
Stock Splits
The last stock split was on January 12, 2021. It was a reverse split with a ratio of 0.0032467.
Last Split Date | Jan 12, 2021 |
Split Type | Reverse |
Split Ratio | 0.0032467 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |